+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The Protective Effects of Ciji-Hua'ai-Baosheng II Formula on Chemotherapy-Treated H 22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis



The Protective Effects of Ciji-Hua'ai-Baosheng II Formula on Chemotherapy-Treated H 22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis



Frontiers in Pharmacology 9: 1539



Ciji-Hua'ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice with transplanted H22 hepatocellular carcinoma were employed in this study. Ninety-two mice were injected subcutaneously with H22 HCC cell suspension into the right anterior armpit. After mice were treated with 5-fluorine pyrimidine (5-FU), they were divided into six groups as untreated group, 5-FU group, 5-FU plus Yangzheng Xiaoji Capsule group and three groups of 5-FU plus different concentrations of CHB-II-F. Twenty mice were euthanized after 7 days of treatment in untreated and medium concentration of CHB-II-F groups and all other mice were euthanized after 14 days of treatment. Herbal components/metabolites were analyzed by UPLC-MS. Tumors were evaluated by weight and volume, morphology of light and electron microscope, and cell cycle. Apoptosis were examined by apoptotic proteins expression by western blot. Four major components/metabolites were identified from serum of mice treated with CHB-II-F and they are β-Sitosterol, Salvianolic acid, isobavachalcone, and bakuchiol. Treatment of CHB-II-F significantly increased body weights of mice and decreased tumor volume compared to untreated group. Moreover, CHB-II-F treatment increased tumor cells in G0-G1 transition instead of in S phase. Furthermore, CHB-II-F treatment increased the expression of pro-apoptotic proteins and decreased the expression anti-apoptotic protein. Therefore, CHB-II-F could improve mice general condition and reduce tumor cell malignancy. Moreover, CHB-II-F regulates apoptosis of tumor cells, which could contribute its protective effect on chemotherapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066113855

Download citation: RISBibTeXText

PMID: 30670974

DOI: 10.3389/fphar.2018.01539


Related references

Effects of Ciji Hua'ai Baosheng granule formula (CHBGF) on life time, pathology, peripheral blood cells of tumor chemotherapy model mouse with H22 hepatoma carcinoma cells. African Journal of Traditional Complementary and Alternative Medicines 11(4): 94, 2014

The effects of Ciji-Hua'ai-Baosheng on immune function of mice with H 22 hepatocellular carcinoma receiving chemotherapy. Biomedicine and PharmacoTherapy 101: 898-909, 2018

The effects of Ciji-Huaai-Baosheng on immune function of mice with H 22 hepatocellular carcinoma receiving chemotherapy. Biomedicine & PharmacoTherapy 101: 898-909, 2018

Safety Evaluation of a New Traditional Chinese Medical Formula, Ciji-Hua'ai-Baosheng II Formula, in Adult Rodent Models. Evidence-BasedComplementaryandAlternativeMedicine2019:3659890, 2019

Efficacy of Ciji Hua'ai Baosheng formula on the expressions of vascular endothelial growth factor, kinase insert domain-containing receptor. Journal of Traditional Chinese Medicine 37(1): 88-95, 2017

The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy. Journal of Ethnopharmacology 190: 1-12, 2016

2-methoxyjuglone induces apoptosis in HepG2 human hepatocellular carcinoma cells and exhibits in vivo antitumor activity in a H22 mouse hepatocellular carcinoma model. Journal of Natural Products 76(5): 889-895, 2013

Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model. International Journal of Oncology 40(4): 1298-1304, 2012

Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 18(12): 900-904, 2010

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Research 66(24): 11851-8, 2006

Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World Journal of Gastroenterology 13(24): 3374-3379, 2007

Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study. World Journal of Gastroenterology 13(41): 5465-5470, 2007

Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model. Cancer Immunology ImmunoTherapy 64(10): 1305-1314, 2015

A Hepatocellular Carcinoma of Massive Arterioportal Shunts Without Tumor Stain Treated with CDDP Two-Route Chemotherapy A Case Report. Angiology 41(9): 737-740, 1990

A hepatocellular carcinoma of massive arterioportal shunts without tumor stain treated with CDDP two-route chemotherapy--a case report. Angiology 41(9 Pt 1): 737-740, 1990